What we are all waiting for is the legalization of cannabis at a federal level. Should this happen, big businesses will have their chance to “come out” and go after the cannabis billions. For now, the majority are afraid of blatantly antagonizing the law.
The pharma industry is arguably the most profitable industry in the United States today. The cannabis industry, on the other hand, is among the fastest-growing industries in the US currently. The merger by Novartis and Tilray is just a drop in the ocean for what may be coming in the next few years, once legalization at fed level happens.
GW Pharmaceuticals, a British-based pharmaceutical company had a breakthrough last year when the FDA approved a CBD-based drug derived from the cannabis plant, for the treatment of intractable childhood seizures. The company’s first product, Sativex, has already been available in pharmacies across Europe and Canada for many years now.
